Related Experiment Video
Updated: Nov 24, 2025
19:57
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
18.9K
A COMMENTARY ON IMPROVING CLOZAPINE ACCESSIBILITY AND REDUCING TREATMENT COST
1VA Boston Healthcare System, Boston MA and Harvard Medical School Department of Psychiatry, Boston MA.
Psychiatry Research
|December 28, 2020
Summary
Clozapine is underutilized due to strict blood monitoring. Evidence shows minimal safety benefits from long-term monitoring, suggesting updated guidelines are needed.
Area of Science:
- Pharmacology
- Psychiatry
- Hematology
Background:
- Clozapine is an effective antipsychotic but is underutilized globally.
- Frequent blood monitoring is the primary barrier to clozapine treatment.
- Concerns about blood dyscrasias led to intensive monitoring protocols.
Purpose of the Study:
- To re-evaluate the necessity of continuous, intensive blood monitoring for clozapine therapy.
- To advocate for updated monitoring guidelines based on current evidence.
- To address the underutilization of clozapine due to monitoring burdens.
Main Methods:
- Review of accumulated evidence on clozapine-induced blood dyscrasias.
- Analysis of safety benefits versus risks of prolonged blood monitoring.
- Examination of healthcare system responses to monitoring during the COVID-19 pandemic.
Main Results:
- Evidence suggests minimal safety benefits from blood monitoring beyond the first year of clozapine treatment.
- The risk of serious blood dyscrasias decreases significantly after initial treatment phases.
- Temporary relaxation of monitoring during the pandemic did not lead to widespread adverse events.
Conclusions:
- Current clozapine monitoring guidelines are overly stringent and not evidence-based.
- Reducing the frequency of blood monitoring can improve clozapine accessibility.
- Updated guidelines should reflect the actual, low risk of blood dyscrasias with long-term clozapine use.
Related Concept Videos
01:28Drug Therapy
156
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
156
01:26Psychosis: Goals of Pharmacotherapy
322
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
322
01:22Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
66
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
66
01:28Psychosis and Antipsychotic Drugs: Overview
631
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
631
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
83
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
83
01:29Therapeutic Drug Monitoring: Affecting Factors
91
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
91